Manufacturing, Expression Systems

>

Latest News

Lonza Invests in Microbial Development Lab Expansion

November 18th 2021

Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.

KGI Team Adapts Vaccine Development Work to Address COVID-19

August 12th 2021

Catalent Biologics Launches New Cell Line Expression Technology

July 22nd 2021

Thermo Fisher Scientific’s Clinic Solution Aims to Accelerate Biologic Drug Development

June 30th 2021

MilliporeSigma Launches Lentiviral Production Platform for Cell and Gene Therapies

October 16th 2020

More News